Can Keflex (Cephalexin) be ordered for the treatment of cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Keflex (Cephalexin) Be Ordered for Cellulitis?

Yes, cephalexin (Keflex) is an appropriate and guideline-recommended first-line antibiotic for the treatment of typical, non-purulent cellulitis.

Primary Indication and FDA Approval

  • Cephalexin is FDA-approved for skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes, which are the primary pathogens in cellulitis 1
  • The Infectious Diseases Society of America (IDSA) explicitly lists cephalexin as a suitable oral agent for typical cellulitis cases 2

When to Use Cephalexin for Cellulitis

For non-purulent cellulitis (the typical presentation):

  • Cephalexin should be prescribed as monotherapy for patients presenting with diffuse erythema, warmth, swelling, and tenderness without purulent drainage 2, 3
  • The majority of non-purulent cellulitis cases are caused by β-hemolytic streptococci or methicillin-sensitive S. aureus, making cephalexin an appropriate choice 3
  • A 5-day course is as effective as a 10-day course if clinical improvement occurs by day 5 2

MRSA coverage is NOT routinely needed:

  • Multiple high-quality randomized controlled trials demonstrate that adding trimethoprim-sulfamethoxazole to cephalexin provides no additional benefit for non-purulent cellulitis 4, 5
  • A 2017 JAMA trial of 496 patients showed clinical cure in 85.5% with cephalexin alone versus 83.5% with cephalexin plus trimethoprim-sulfamethoxazole (no significant difference) 4
  • MRSA is an unusual cause of typical cellulitis, with β-lactams like cephalexin successful in 96% of cases even in high-MRSA prevalence areas 2

When to Consider Alternative or Additional Coverage

Add MRSA-active antibiotics only when:

  • Purulent drainage is present 2
  • Penetrating trauma occurred, especially from injection drug use 2
  • Evidence of MRSA infection exists elsewhere or documented nasal MRSA colonization 2
  • Systemic inflammatory response syndrome (fever, hypotension, delirium) is present 2

For these high-risk scenarios, combine cephalexin with:

  • Trimethoprim-sulfamethoxazole, OR
  • Doxycycline, OR
  • Use clindamycin monotherapy (covers both streptococci and MRSA) 2

Dosing and Duration

  • Standard dose: Cephalexin 500 mg orally four times daily 1
  • Duration: 5-6 days for uncomplicated cellulitis with clinical improvement 2
  • Extend treatment only if infection has not improved after 5 days 2

Essential Adjunctive Measures

  • Elevate the affected extremity to promote drainage of edema and inflammatory substances 2, 6
  • Treat predisposing conditions including tinea pedis, venous insufficiency, or toe web abnormalities 2
  • Consider prednisone 40 mg daily for 7 days in non-diabetic adults to hasten resolution (weak recommendation) 2

Critical Pitfalls to Avoid

Do not routinely add MRSA coverage: The evidence is clear that empiric MRSA coverage for non-purulent cellulitis provides no benefit and contributes to unnecessary broad-spectrum antibiotic use 4, 5

Do not treat for 10-14 days by default: Shorter 5-6 day courses are equally effective and reduce antibiotic exposure 2

Do not prescribe antibiotics without addressing predisposing factors: Failure to treat underlying conditions like tinea pedis increases recurrence risk 2

Recognize cellulitis mimics: Venous stasis dermatitis, contact dermatitis, and lymphedema are frequently misdiagnosed as cellulitis and do not require antibiotics 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.